Shenzhen City Fengdian Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen City Fengdian Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SOPXCOCM. The owner is based in  Shenzhen, Guangdong.

401C, Bldg. 50, Bantian 3rd Industrial

 Shenzhen, Guangdong 518129 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SOPXCOCM
SOPXCOCM
Registered 2022

Trademark Classifications

Shenzhen City Fengdian Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen City Fengdian Technology Co., Ltd. have?

Shenzhen City Fengdian Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen City Fengdian Technology Co., Ltd. file in?

Shenzhen City Fengdian Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen City Fengdian Technology Co., Ltd.'s most well-known trademarks?

Shenzhen City Fengdian Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SOPXCOCM. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen City Fengdian Technology Co., Ltd.'s trademark registration success rate?

Shenzhen City Fengdian Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.